Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026)
Precision Biosciences' (DTIL) quarterly Interest & Investment Income came in at $999000.0 in Q1 2026, down 24.49% year-on-year from $1.3 million in Q1 2025, and up 29.24% on a QoQ basis from $773000.0 in Q4 2025.
Precision Biosciences (DTIL) Interest & Investment Income (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Interest & Investment Income data on file, last reported at $999000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 24.49% year-over-year to $999000.0 in Q1 2026; TTM through Mar 2026 was $3.9 million, a 39.05% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 37.32% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $999000.0, up from $773000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for DTIL reached as high as $2.0 million in Q1 2023 and fell as low as $172000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.4 million across 5 years, with a median of $1.5 million in 2024.
- Across the five-year window, Interest & Investment Income surged 2974.6% in 2022 and sank 48.26% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $1.9 million in 2022, then slipped by 5.68% to $1.8 million in 2023, then dropped by 18.23% to $1.5 million in 2024, then sank by 48.26% to $773000.0 in 2025, then advanced by 29.24% to $999000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $999000.0 in Q1 2026, $773000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | 999,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 999,000.00 |
| Dec 31, 2025 | 773,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 48,000.00 |